Welcome to our dedicated page for Hanover Bancorp SEC filings (Ticker: HNVR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hanover Bancorp, Inc. (HNVR) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures as a Nasdaq-listed bank holding company. Through these documents, investors can review how Hanover reports its commercial banking activities, capital structure, and risk profile as the parent of Hanover Community Bank.
Current reports on Form 8-K feature prominently in Hanover’s filing history. The company uses Form 8-K to announce quarterly and annual earnings results, furnish press releases on financial performance, and provide investor presentation materials under Regulation FD. These filings give detail on net interest income, net interest margin, pre-provision net revenue, asset quality, loan and deposit trends, and quarterly cash dividend declarations on common and Series A preferred shares.
Hanover also files 8-Ks for material corporate events, such as its 2025 reincorporation merger in which Hanover Bancorp, Inc., a New York corporation, merged into a Maryland corporation of the same name to change its domicile. The related 8-K describes the Agreement and Plan of Merger, the continuation of the company’s business under Maryland law, the conversion of outstanding shares into Maryland-incorporated shares on a one-for-one basis, and the succession of the Maryland entity to all rights, assets, liabilities, and obligations of the former New York corporation.
On Stock Titan, these filings are updated in near real time as they appear on EDGAR. AI-powered summaries help explain the key points in lengthy documents, highlight items such as earnings trends, changes in corporate structure, and capital actions, and make it easier to understand the implications of each filing without reading every page. Users can quickly locate Hanover’s earnings-related 8-Ks, Regulation FD disclosures with investor presentations, and corporate governance filings related to charter and bylaw changes.
For investors analyzing HNVR, this page serves as a focused view of Hanover Bancorp’s SEC reporting history, combining raw filings with AI-generated insights to clarify complex financial and legal information.
Hanover Bancorp, Inc. announced that McClelland “Mac” Wilcox, President of the company and its banking subsidiary, will leave as part of a management restructuring initiative. His last day is expected to be March 31, 2026, under his existing employment agreement.
Subject to signing and not revoking a Transition Agreement and General Release, Mr. Wilcox will receive a severance benefit of approximately $2.15 million under that agreement. The Board has appointed Michael Puorro, currently Chairman and Chief Executive Officer, to also serve as President of both the company and the bank, effective immediately after Mr. Wilcox’s departure.
AllianceBernstein L.P. has filed Amendment No. 1 to a Schedule 13G reporting its beneficial ownership of Hanover Bancorp Inc. common stock. The firm reports holding 373,571 shares, representing 5.2% of the outstanding common stock as of the event date.
The shares are held solely for investment purposes in client discretionary investment advisory accounts. AllianceBernstein has sole power to vote and dispose of these 373,571 shares, with no shared voting or dispositive power, and states they are held in the ordinary course of business, not to change or influence control of Hanover Bancorp.
Fourthstone LLC and related funds have updated their ownership disclosure for Hanover Bancorp, Inc. The group reports beneficial ownership of 516,702 shares of Hanover common stock, representing 7.18% of the outstanding shares, based on 7,192,390 shares outstanding as of October 31, 2025.
Fourthstone holds the shares on behalf of its advisory clients, with voting and dispositive power shared among Fourthstone, affiliated investment funds, and managing member L. Phillip Stone IV. The filers state the shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Hanover Bancorp.
Hanover Bancorp, Inc. director Philip A. Okun reported receiving a grant of 1,592 shares of common stock on February 5, 2026. The shares are restricted stock awarded at a price of $0.0000 per share and are subject to forfeiture.
The grant vests over three years, with one-third of the shares vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029. Following this award, Okun beneficially owns 42,669 shares of Hanover Bancorp common stock in direct ownership.
Hanover Bancorp, Inc. director Michael David Katz, M.D. reported receiving a grant of 1,592 shares of common stock on February 5, 2026 at a price of $0.0000 per share. These restricted shares are subject to forfeiture and vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.
After this grant, he directly holds 152,202 common shares, and also has indirect holdings of 25 shares as custodian for Grandchild #1, 40 shares as custodian for Grandchild #2, and 96,760 shares as beneficiary of a trust.
Hanover Bancorp, Inc. reported that its EVP & Chief Risk Officer, John P. Vivona, received a grant of 1,338 shares of common stock on February 5, 2026. The shares were granted at a price of $0.0000 per share as restricted stock subject to forfeiture.
The grant vests over three years, with one-third of the shares vesting on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. Following this award, Vivona beneficially owns 5,247 shares of Hanover Bancorp common stock, held directly.
Hanover Bancorp director Elena Sisti reported a grant of 1,592 shares of common stock. The shares are restricted stock granted at a price of $0.00 per share and are subject to forfeiture. They will vest over three years, with one-third vesting on each of March 1, 2027, March 1, 2028, and March 1, 2029.
After this award, Sisti directly beneficially owns 105,016 shares of Hanover Bancorp common stock. An additional 51,018 shares are reported as indirectly owned through her spouse.
Hanover Bancorp, Inc. director Robert Golden reported a mix of stock awards and sales. On February 5, 2026, he received 1,592 shares of restricted common stock at $0.0000 per share, vesting in equal thirds on March 1 of 2027, 2028, and 2029. That award brought his directly held shares to 26,268.
On February 5 and 6, 2026, trusts for his benefit, where his spouse is trustee, sold 500 shares at $23.50 and 700 shares at $23.60, leaving 195,358 shares in those trusts. He also reports additional indirect holdings through various trusts, a controlled LLC, and his spouse, including 80,769 shares in trusts for a sibling and 25,000 shares held by his spouse.
Hanover Bancorp, Inc. director Abraham Varkey reported a grant of 1,592 shares of common stock on February 5, 2026 at a price of $0.0000 per share. These shares are restricted stock subject to forfeiture.
The restricted stock vests over three years, with one-third vesting on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029. After this grant, Varkey beneficially owns 45,670 common shares directly and 13,334 common shares indirectly through his spouse.
Hanover Bancorp, Inc. director John R. Sorrenti reported an equity award of common stock. On February 5, 2026, he received 1,592 shares of restricted common stock at a price of $0.0000 per share, increasing his holdings to 47,209 common shares owned directly.
The award is structured as restricted stock subject to forfeiture and time-based vesting. The shares vest in three equal installments, with one-third scheduled to vest on March 1, 2027, one-third on March 1, 2028, and the final third on March 1, 2029, aligning director compensation with longer-term company performance.